Hürrem Bodur

Hürrem Bodur

Auto-generated profile, based on publicly available information

Hürrem Bodur

Health Science University Turkey, Ankara City Hospital, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Emerging Infectious Diseases
Verified
Journal Article
Open access
HBHürrem Bodur
Hürrem Bodur
EAEsragül Akinci
Esragül Akinci
SASibel Ascioglu
Sibel Ascioglu
PÖPinar Öngürü
Pinar Öngürü
YUYavuz Uyar
Yavuz Uyar
To investigate Crimean-Congo hemorrhagic fever virus in Turkey, we conducted a seroepidemiologic survey during January–April 2009. Seroprevalence of infection was 10% in a sample from an outbreak region and increased with patient age, indicating that the virus had been previously present in Turkey. We also estimated that 88% of infections were subclinical.

1 September 2015 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
HLHakan Leblebicioglu
Hakan Leblebicioglu
MSMustafa Sunbul
Mustafa Sunbul
ZMZiad Memish
Ziad Memish
JAJaffar A. Al-Tawfiq
Jaffar A. Al-Tawfiq
HBHurrem Bodur
Hurrem Bodur
ZHZahra Hasan
Zahra Hasan
Crimean-Congo hemorrhagic fever (CCHF) is endemic in Eurasian countries such as, Turkey, Pakistan, Afghanistan and Iran. CCHF virus is spread by the Hyalomma tick, which is found mainly on cattle and sheep. Muslim countries, in which these animals are sacrificed during Eid-Al-Adha, are among the countries where CCHF is endemic, and it has been observed that CCHF is associated with practices surrounding the Eid-ad-Adha festival. The dates for Eid-Al-Adha drift 10 days earlier in each year according to Georgian calendar. In previous years Eid-al-Adha occurred in autumn-winter months however in the next 10-15 years it will be take place in the summer months when CCHF is more prevalent. This may lead to a rise in the number of cases due to increased dissemination of CCHF virus with uncontrolled animal movements in and between countries. This consensus report focuses on the variable practices regarding animal handling in different regions and possible preventative measures to reduce the incidence of CCHF. Environmental hygiene and personal protection are essential parts of prevention. There is a need for international collaborative preparedness and response plans for prevention and management of CCHF during Eid-Al-Adha in countries where the disease is prevalent.

9 February 2016 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
MYMESUT YILMAZ
MESUT YILMAZ
NENazif Elaldi
Nazif Elaldi
IBİlker İnanç Balkan
İlker İnanç Balkan
FAFerhat Arslan
Ferhat Arslan
ABAyşe Alga Batırel
Ayşe Alga Batırel
AMAli Mert
Ali Mert
Staphylococcus aureus is one of the causes of both community and healthcare-associated bacteremia. The attributable mortality of S. aureus bacteremia (SAB) is still higher and predictors for mortality and clinical outcomes of this condition are need to be clarified. In this prospective observational study, we aimed to examine the predictive factors for mortality in patients with SAB in eight Turkish tertiary care hospitals. Adult patients with signs and symptoms of bacteremia with positive blood cultures for S. aureus were included. All data for episodes of SAB including demographics, clinical and laboratory findings, antibiotics, and outcome were recorded for a 3-year (2010–2012) period. Cox proportional hazard model with forward selection was used to assess the independent effect of risk factors on mortality. A 28-day mortality was the dependent variable in the Cox regression analysis. A total of 255 episodes of SAB were enrolled. The median age of the patients was 59 years. Fifty-five percent of the episodes were considered as primary SAB and vascular catheter was the source of 42.1 %. Healthcare associated SAB was defined in 55.7 %. Blood cultures yielded methicillin-resistant S. aureus (MRSA) as a cause of SAB in 39.2 %. Initial empirical therapy was inappropriate in 28.2 %. Although overall mortality was observed in 52 (20.4 %), 28-day mortality rate was 15.3 %. Both the numbers of initial inappropriate empirical antibiotic treatment and the median hours to start an appropriate antibiotic between the cases of fatal outcome and survivors after fever onset were found to be similar (12/39 vs 60/216 and 6 vs 12 h, respectively; p > 0.05). High Charlson comorbidity index (CCI) score (p = 0.002), MRSA (p = 0.017), intensive care unit (ICU) admission (p < 0.001) and prior exposure to antibiotics (p = 0.002) all were significantly associated with mortality. The Cox analysis defined age [Hazard Ratio (HR) 1.03; p = 0.023], ICU admission (HR 6.9; p = 0.002), and high CCI score (HR 1.32; p = 0.002) as the independent predictive factors mortality. The results of this prospective study showed that age, ICU stay and high CCI score of a patient were the independent predictors of mortality and MRSA was also significantly associated with mortality in SAB.

1 August 2010 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
HBHürrem Bodur
Hürrem Bodur
EAEsragül Akıncı
Esragül Akıncı
PÖPınar Öngürü
Pınar Öngürü
YUYavuz Uyar
Yavuz Uyar
BBBilkay Baştürk
Bilkay Baştürk
BKBircan Ünal Kayaaslan
Bircan Ünal Kayaaslan

19 March 2021 in Rheumatology International
Verified
Journal Article
Open access
PDF file
ABAliye Bastug
Aliye Bastug
HAHalide Aslaner
Halide Aslaner
YBYesim Aybar Bilir
Yesim Aybar Bilir
NKNizamettin Kemirtlek
Nizamettin Kemirtlek
FGFahriye Melis Gursoy
Fahriye Melis Gursoy
HBHurrem Bodur
Hurrem Bodur
Multisystem inflammatory syndrome in adults (MIS-A) is a new syndrome related with COVID-19. A case-based review was performed to present real-life experiences in terms of main findings and treatment options. We described two cases with the diagnosis of MIS and searched the literature to review all reported ≥ 18-year-old cases. The PubMed, Scopus, and Web of Science databases were searched. All relevant articles from January 2020 to February 2021 were reviewed. An adolescent and an adult patient (18 and 40 years-old, respectively) with the diagnosis of MIS were presented. Both had the consistent clinical findings with the case definition criteria. Although steroid, intravenous immunoglobulin (IVIG) and supportive care treatments have been suggested in the literature, there exists no treatment guideline for MIS-A. The clinical and laboratory findings of the patients progressively improved with the implementation of the IVIG and the pulse steroid treatments. A total of 51 cases (≥ 18 years-old) with MIS were analyzed. Mean age was 29.4 ± 10 years. Fever (80.4%), gastrointestinal (72.5%), and respiratory symptoms (54.9%) were the predominant symptoms. Cardiovascular abnormalities were the most frequent reported findings (82.4%, 42/51). The dermatological and conjunctival findings were reported in 39.2% and 35.3% of the patients, respectively. The increased level of inflammatory biomarkers was remarkable. Most of the patients were treated successfully with steroid and IVIG. Clinicians managing adult patients should keep in mind the development risk of MIS related with SARS-CoV-2 infection to perform necessary interventions properly without delay. IVIG and pulse steroid treatments are the effective options on clinical improvement.

1 January 2011 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
HBHürrem Bodur
Hürrem Bodur
AEAyşe Erbay
Ayşe Erbay
EAEsragül Akıncı
Esragül Akıncı
PÖPınar Öngürü
Pınar Öngürü
NBNurhayat Bayazıt
Nurhayat Bayazıt
AKAyhan Kubar
Ayhan Kubar